Neural Stem Cell Delivery of an Oncolytic Adenovirus in Newly Diagnosed Malignant Glioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neural Stem Cell Delivery of an Oncolytic Adenovirus in Newly Diagnosed Malignant Glioma: A First-in-Human, Phase 1, Dose-Escalation Trial
Lancet Oncol 2021 Jun 29;[EPub Ahead of Print], J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, IV Balyasnikova, JP Chandler, J Portnow, MC Tate, P Kumthekar, RV Lukas, SA Grimm, AK Adams, CD Hébert, TV Strong, C Amidei, VA Arrieta, M Zannikou, C Horbinski, H Zhang, KB Burdett, DT Curiel, S Sachdev, KS Aboody, R Stupp, MS LesniakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.